AFP
Alpha-fetoprotein
Also known as: FETA, FETA_HUMAN, HPAFP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02771
- Gene
- AFP
- Ensembl
- ENSG00000081051
- Chromosome
- 4
- Canonical length
- 609 aa
- Protein class
- Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes alpha-fetoprotein, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatocarcinoma and with teratoma, and has prognostic value for managing advanced gastric cancer. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. [provided by RefSeq, Oct 2019]
Canonical amino-acid sequenceUniProt
609 residues, UniProt reviewed canonical sequence.
>P02771|AFP
1 MKWVESIFLI FLLNFTESRT LHRNEYGIAS ILDSYQCTAE ISLADLATIF FAQFVQEATY
61 KEVSKMVKDA LTAIEKPTGD EQSSGCLENQ LPAFLEELCH EKEILEKYGH SDCCSQSEEG
121 RHNCFLAHKK PTPASIPLFQ VPEPVTSCEA YEEDRETFMN KFIYEIARRH PFLYAPTILL
181 WAARYDKIIP SCCKAENAVE CFQTKAATVT KELRESSLLN QHACAVMKNF GTRTFQAITV
241 TKLSQKFTKV NFTEIQKLVL DVAHVHEHCC RGDVLDCLQD GEKIMSYICS QQDTLSNKIT
301 ECCKLTTLER GQCIIHAEND EKPEGLSPNL NRFLGDRDFN QFSSGEKNIF LASFVHEYSR
361 RHPQLAVSVI LRVAKGYQEL LEKCFQTENP LECQDKGEEE LQKYIQESQA LAKRSCGLFQ
421 KLGEYYLQNA FLVAYTKKAP QLTSSELMAI TRKMAATAAT CCQLSEDKLL ACGEGAADII
481 IGHLCIRHEM TPVNPGVGQC CTSSYANRRP CFSSLVVDET YVPPAFSDDK FIFHKDLCQA
541 QGVALQTMKQ EFLINLVKQK PQITEEQLEA VIADFSGLLE KCCQGQEQEV CFAEEGQKLI
601 SKTRAALGVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AFP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 3.4 nTPM
Expression across tissuesHPA
Tissue
- liver: 3.4 nTPM
- breast: 0.3 nTPM
- epididymis: 0.2 nTPM
- adrenal gland: 0.1 nTPM
- ovary: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- hepatocytes: 141 nCPM
- breast hormone-responsive cells: 24 nCPM
- epididymal efferent duct absorptive cells: 19 nCPM
- epididymal basal cells: 6.7 nCPM
- hepatic stellate cells: 6.5 nCPM
- breast myoepithelial cells: 4.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AFP.
Disease | AllUniProt
Conditions AFP is implicated in, by any mechanism.
- Alpha-fetoprotein deficiency (AFPD) MIM:615969
- Alpha-fetoprotein, hereditary persistence (HPAFP) MIM:615970
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 104 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Alpha-fetoprotein deficiency
- Premature ovarian failure
Disease | ImmuneIEDB
Conditions an epitope on AFP was assayed in.
- hepatocellular carcinoma T cell
- invasive ductal carcinoma T cell
- hepatitis C T cell
ReferencesPubMed · IEDB
Publications for AFP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
2008 · Neurobiol Dis · RCR 0.7 · 28 citations - Mechanisms of fetal demise in pregnant mice immunized to murine alpha-fetoprotein.
1984 · Am J Reprod Immunol (1980) · RCR 0.4 · 9 citations - Distribution-analyzing latex immunoassay (DALIA): methods for determination of antigen and for elimination of non-specific reaction induced by rheumatoid factor.
1989 · Chem Pharm Bull (Tokyo) · RCR 0.2 · 3 citations - [Abortive effect of autologous anti-alpha-fetoprotein antibodies in the rat].
1978 · C R Acad Hebd Seances Acad Sci D · RCR 0.2 · 5 citations - [Presence of anti-AFP-antibody producing B cells in peripheral blood lymphocyte of hepatocellular carcinoma patient].
1984 · Nihon Shokakibyo Gakkai Zasshi · RCR 0 · 1 citations
Reference: B cellIEDB
1 publication
- Advancing liver cancer treatment with dual-targeting CAR-T therapy.
2025 · J Nanobiotechnology · RCR 3.7 · 12 citations
Reference: T cellIEDB
11 publications
- Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
2014 · Hepatology · RCR 7.8 · 298 citations - Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
2021 · Immunity · RCR 5.3 · 114 citations - High-throughput determination of the antigen specificities of T cell receptors in single cells.
2018 · Nat Biotechnol · RCR 4.5 · 163 citations - Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma.
2017 · Gastroenterology · RCR 2 · 69 citations - A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.
2013 · Nat Med · RCR 1.8 · 81 citations
Show 6 more
- Tuning T-Cell Receptor Affinity to Optimize Clinical Risk-Benefit When Targeting Alpha-Fetoprotein-Positive Liver Cancer.
2019 · Hepatology · RCR 1.5 · 48 citations - HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection.
2019 · Liver Cancer · RCR 1.2 · 30 citations - Identification of an HLA-A*24:02-restricted α-fetoprotein signal peptide-derived antigen and its specific T-cell receptor for T-cell immunotherapy.
2020 · Immunology · RCR 0.7 · 17 citations - Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization.
2023 · Vaccines (Basel) · RCR 0.4 · 4 citations - A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma.
2020 · Sci Rep · RCR 0.4 · 9 citations - Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development.
2025 · Hepatol Commun · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- homeostasis of number of cells
- immune response
- ovulation from ovarian follicle
- progesterone metabolic process
- response to nutrient levels
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AFP as an antibody target. Whether an autoantibody or antibody against AFP could matter depends on whether native AFP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AFP is annotated as secreted, so native AFP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label AFP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...